Screener
Upstream Bio, Inc. UPB Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Upstream Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesAndOtherLiabilities.
The source filing: Upstream Bio, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 7:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-343417
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $2,314 | $2,726 |
| Accrued expenses and other current liabilities | 6,946 | 10,006 |
| Operating lease liabilities, current portion | 728 | 720 |
| Total current liabilities | 9,988 | 13,452 |
| Operating lease liabilities, net of current portion | 226 | 549 |
| Total liabilities | 10,214 | 14,001 |
Item 1. Financial Statements.
FAQ
- What is Upstream Bio, Inc.'s accrued expenses?
- Upstream Bio, Inc. (UPB) reported accrued expenses of $6.95M in Q2 2026.
- How has Upstream Bio, Inc.'s accrued expenses changed year-over-year?
- Upstream Bio, Inc.'s accrued expenses decreased by 9.4% year-over-year, from $7.67M to $6.95M.
- What is the long-term trend for Upstream Bio, Inc.'s accrued expenses?
- Over 2 years (2023 to 2025), Upstream Bio, Inc.'s accrued expenses has grown at a 49.4% compound annual growth rate (CAGR), from $4.48M to $10.01M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Upstream Bio, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude